News & Updates

Patients with ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock may benefit from a significantly higher survival rate at 6 months through the routine use of a microaxial flow pump in combination with standard care as compared with standard care alone, as shown in a study presented at the recent ACC.24.

Children and adolescents with Tourette syndrome (TS) may benefit from ecopipam, a first-in-class selective dopamine-1 (D1) receptor antagonist, as it reduced the number of tics and level of daily interference in a post hoc analysis of the phase IIb D1AMOND trial.

There is no short supply of standardized treatment protocols (STPs) for hypertension across the globe, but many of these can be further improved through interventions targeting alignment with the latest evidence-based guidelines and engagement with multiple stakeholders, suggests a study.